Cite
Leptomeningeal metastasis: a Response Assessment in Neuro-Oncology critical review of endpoints and response criteria of published randomized clinical trials.
MLA
Chamberlain, Marc, et al. “Leptomeningeal Metastasis: A Response Assessment in Neuro-Oncology Critical Review of Endpoints and Response Criteria of Published Randomized Clinical Trials.” Neuro-Oncology, vol. 16, no. 9, Sept. 2014, pp. 1176–85. EBSCOhost, https://doi.org/10.1093/neuonc/nou089.
APA
Chamberlain, M., Soffietti, R., Raizer, J., Rudà, R., Brandsma, D., Boogerd, W., Taillibert, S., Groves, M. D., Le Rhun, E., Junck, L., van den Bent, M., Wen, P. Y., & Jaeckle, K. A. (2014). Leptomeningeal metastasis: a Response Assessment in Neuro-Oncology critical review of endpoints and response criteria of published randomized clinical trials. Neuro-Oncology, 16(9), 1176–1185. https://doi.org/10.1093/neuonc/nou089
Chicago
Chamberlain, Marc, Riccardo Soffietti, Jeffrey Raizer, Roberta Rudà, Dieta Brandsma, Willem Boogerd, Sophie Taillibert, et al. 2014. “Leptomeningeal Metastasis: A Response Assessment in Neuro-Oncology Critical Review of Endpoints and Response Criteria of Published Randomized Clinical Trials.” Neuro-Oncology 16 (9): 1176–85. doi:10.1093/neuonc/nou089.